SEC Form D · filed May 7, 2020
Navitor Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Rajeev P. Dadoo · Cambridge, MADirectorThomas P. Hughes · Cambridge, MAExecVinzenz P. Ploerer · Cambridge, MADirectorAlan P. Crane · Cambridge, MADirectorKevin P. Bitterman · Cambridge, MADirectorMarian Nakada · Cambridge, MADirectorJohn P. Creecy · Cambridge, MAExec · DirectorDavid P. Madden · Cambridge, MADirectorRichard Lundberg · Cambridge, MAExecCatenary Carbon GP, LLC · Miami, FLExec · DirectorAaron Katz · New York, NYDirectorJonathan Neiss · NEW YORK, NYDirectorCapital Management, Inc. Conrad · Islandia, NYDirectorEkta S. Dang · Fremont, CADirectorJosh Curry · Frisco, TXDirectorDonald E. Conrad · Islandia, NYDirectorChadwick J. Wasilenkoff · Indio, CAExecGeorg Vlasuk · Cambridge, MADirectorPawel Gierynski · Warsaw, R9DirectorStephen Richmond · Warsaw, R9DirectorGeorge Swirski · Warsaw, R9DirectorWilliam Manby · Akron, OHDirectorTullis Growth Partners Ii, L.L.C · PALM BEACH GARDENS, FLExec · DirectorThomas L. Tuttle · New York, NYDirectorMichael Levenberg · Philadelphia, PADirectorSeth Lehr · Philadelphia, PAExecGeorg Vlasuk · Cambridge, MADirectorRichard Lundberg · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗